Lexaria Bioscience Corp
NASDAQ:LEXX 4:00:00 PM EDT
| Market Cap (Intraday) | 17.37M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.91 |
| 50-Day MA | $1.07 |
| 200-Day MA | $1.89 |
Lexaria Bioscience Corp Stock, NASDAQ:LEXX
740 McCurdy Road, Suite 100, Kelowna, British Columbia V1X 2P7
Canada
Phone: +1.250.765.6424
Number of Employees: 7
Description
Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. It operates through the following segments: IP Licensing, B2B Product, Research and Development, and Corporate. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.